// App-Quantinova.ai

T1204 2016 AHA : Novel, Highly Selective Direct Thrombin Inhibitors: Efficacy, Safety, and Tolerability Studies

Researchers

Presenter

  • Subhadra Dash

Principal Investigators

  • Daniel Clemens

  • Angels Estiarte

  • Kevin Short

  • Timothy Shiau

  • David Williams

  • Mohan Sivaraja

  • Anirban Datta

  • David Kita

  • Kenneth Lin

  • Georg Neckermann

  • Simon Yau

  • Elaine To

  • Lev Igoudin

  • Samuel Keutzer

  • Nichole Sandoval

  • Sivan Sizikov

Medical Centers

  • Verseon Corp, San Jose, CA

  • Verseon, Fremont, CA.

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

  • Blood/haematological Diseases

  • Pulmonary/Respiratory Diseases

Disease

  • Venous thrombosis

  • Arrhythmia

Biomarkers

  • N/A

Drug/Treatment

  • Evithrom

  • Warfarin

Outcome

  • N/A

Study Design

  • pharmacokinetics

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved